While IDH-WT tumors retained a poor prognosis and showed no benefit from PCV treatment, improved OS was seen in IDH mutant non-co-deleted tumors, and astrocytic tumors when treated with PCV plus RT. Here, IDH1 is linked to astrocytic tumor.